Aegros jobs and careers
Macquarie Park, Australia
About Aegros
At Aegros we believe access to life saving therapeutic plasma drugs is a human right and not a privilege. Our mission is to put the patient first through innovation and we do this thanks to our Australian invented Haemafrac®, Aegros' unique electroseparation process. Our TGA GMP-approved plasma fractionation plant in Macquarie Park, Sydney, manufactures a hyperimmune immunoglobulin product against Covid-19, made from convalescent plasma. Aegros is currently undertaking the final preparations for the submission of a dossier for the registration of this hyperimmune against Covid-19 on the Australian Register of Therapeutic Goods (ARTG) Simultaneously, Aegros is finishing the upgrade of its existing hyperimmune facility at Macquarie Park NSW to be able to process 100,000l of plasma per year.
- Founded
- 2017
- Employees
- 125
- Headquarters
- Macquarie Park
Leadership
The top of Aegros's org chart, with how many people report into each leader.
Ranjeet Ajmani
Is Chief Executive Officer For Aegros Asia.
20 reports
Janet Bowen
Executive Director, Chief Quality and Regulatory Officer at Aegros Innovations
7 reports
Yair Pilpel
Chief Scientific Officer (CSO)
5 reports
Shawn X. Feng
Head Of Finance Operations
1 report
Christina Chen
Senior Director Of Process Development
1 report
Amir Pourabed
Head of Special Projects
Mike Swan
Chief Marketing Officer
Jobs at Aegros
No open positions right now. Explore more companies on TheJobsMap.